Literature DB >> 19957377

New translational research on novel drugs for hepatitis C virus 1b infection by using a replicon system and human induced pluripotent stem cells.

Hisashi Moriguchi, Raymond T Chung, Chifumi Sato.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 19957377     DOI： 10.1002/hep.23378

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  2 in total

1.  Statin (3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor)-based therapy for hepatitis C virus (HCV) infection-related diseases in the era of direct-acting antiviral agents.

Authors:  Sara Sobhy Kishta; Sobhy Ahmed Kishta; Reem El-Shenawy
Journal:  F1000Res       Date:  2016-02-26

2.  Clinical effects of simvastatin in chronic hepatitis C patients receiving sofosbuvir/daclatasvir combination. A randomized, placebo-controlled, double-blinded study.

Authors:  Hossam Z Mohamed; Nagwa A Sabri; Hossam M Zaki; Sara M Shaheen
Journal:  Clin Exp Hepatol       Date:  2020-05-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.